Topical imiquimod may be effective alternative to surgery for melanoma in situ

Source: Healio, April 2017

Topical imiquimod cream may be an effective treatment for patients with melanoma in situ who are not candidates for surgery, according to long-term study outcomes published in Dermatologic Surgery.

Researchers conducted a retrospective chart review of 12 white patients with biopsy-proven melanoma in situ (seven men; average age, 79 years) who were treated with topical 5% imiquimod cream between 2004 and 2015 at the dermatology section of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Patients were instructed to apply the cream over the affected area for 6 to 12 weeks daily or on weekdays. Patients were excluded from analysis if they had undergone surgical treatment for melanoma in situ.

read the original full article

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories